1. Home
  2. DNLI vs CLSK Comparison

DNLI vs CLSK Comparison

Compare DNLI & CLSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • CLSK
  • Stock Information
  • Founded
  • DNLI 2013
  • CLSK 1987
  • Country
  • DNLI United States
  • CLSK United States
  • Employees
  • DNLI N/A
  • CLSK N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • CLSK Finance: Consumer Services
  • Sector
  • DNLI Health Care
  • CLSK Finance
  • Exchange
  • DNLI Nasdaq
  • CLSK Nasdaq
  • Market Cap
  • DNLI 3.3B
  • CLSK 2.8B
  • IPO Year
  • DNLI 2017
  • CLSK N/A
  • Fundamental
  • Price
  • DNLI $21.93
  • CLSK $11.87
  • Analyst Decision
  • DNLI Strong Buy
  • CLSK Strong Buy
  • Analyst Count
  • DNLI 13
  • CLSK 8
  • Target Price
  • DNLI $38.91
  • CLSK $22.71
  • AVG Volume (30 Days)
  • DNLI 1.1M
  • CLSK 25.6M
  • Earning Date
  • DNLI 02-25-2025
  • CLSK 02-06-2025
  • Dividend Yield
  • DNLI N/A
  • CLSK N/A
  • EPS Growth
  • DNLI N/A
  • CLSK N/A
  • EPS
  • DNLI N/A
  • CLSK N/A
  • Revenue
  • DNLI N/A
  • CLSK $378,968,000.00
  • Revenue This Year
  • DNLI N/A
  • CLSK $143.22
  • Revenue Next Year
  • DNLI $651.24
  • CLSK $29.76
  • P/E Ratio
  • DNLI N/A
  • CLSK N/A
  • Revenue Growth
  • DNLI 204.74
  • CLSK 125.03
  • 52 Week Low
  • DNLI $14.56
  • CLSK $6.41
  • 52 Week High
  • DNLI $33.33
  • CLSK $24.72
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 51.28
  • CLSK 55.00
  • Support Level
  • DNLI $18.52
  • CLSK $9.36
  • Resistance Level
  • DNLI $22.37
  • CLSK $11.43
  • Average True Range (ATR)
  • DNLI 1.31
  • CLSK 0.77
  • MACD
  • DNLI 0.31
  • CLSK 0.25
  • Stochastic Oscillator
  • DNLI 88.57
  • CLSK 84.30

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About CLSK CleanSpark Inc.

Cleanspark Inc is a bitcoin mining company. Through CleanSpark, Inc., and the Company's wholly owned subsidiaries, the company mines bitcoin. The company entered the bitcoin mining industry through its acquisition of ATL. Bitcoin mining is the sole reportable segment of the company.

Share on Social Networks: